{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ08225",
      "entity_text" : "sL-selectin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0923" ],
      "CellType" : [ "cl:CL:0000738" ]
    }
  },
  "verbose_text" : "That hypothesis might be supported by the findings of Czygier et al., who detected increased levels of serum sL-selectin in women with early-stage breast cancer and decreased levels of serum sL-selectin in subjects with advanced stages of the disease (grade III and IV) [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-02T18:10:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T18:07:50Z",
  "trigger" : "levels",
  "evidence" : [ "levels of serum sL-selectin" ],
  "pmc_id" : "5925195",
  "score" : 0
}